ライフサイエンスコーパス: FITC

1 FITC(+) glucan-coated particles (glucan-encapsulated sma

2 FITC-albumin, Lsr-F, or fluorescent polystyrene latex pa

3 FITC-D weighing up to 70-kDa, as well as NaF, reached th

4 FITC-dextran molecules were chosen as models of migrant

5 FITC-labeled aptamer was used as a binder molecule in th

6 FITC-PNA-Antp accumulates in nuclei of keratinocytes, an

7 FITC-TrapG was selectively trapped on purified beta-gluc

8 ining of human neutrophils and anti-Dectin-1-FITC staining of mouse macrophages as well as for their

9 G6-5aSlex-FITC conjugate could specifically capture HT29 cells eve

10 G6-5aSlex-FITC conjugate showed capture efficiency better than FIT

11 fluorescein (376Da) and weakly anionic 70kDa FITC-dextran), probe concentration (50 to 200 ppm), and

12 BBB permeability to 70kDa FITC-Dextran was measured 24h following injury and quant

13 matic cleavage of SA and by staining using a FITC labeled SA selective lectin.

14 iocyanate labeled 3-aminophenylboronic acid (FITC-APBA) as the chemoselective recognition probe of si

15 ((4-(dimethylamino)phenyl)azo) benzoic acid (FITC/DABCYL) FRET pair to produce a signal upon substrat

16 beta-glucuronidase-activated FITC-TrapG did not interfere with beta-glucuronidase act

17 the half-life of intravenously administered FITC-sinistrin, a molecule cleared by glomerular filtrat

18 the cGMP analog 8-bromo-cGMP did not affect FITC-insulin uptake.

19 DLN contained twice more fluorescence after FITC skin painting and twice more donor DC after footpad

20 man blood-sorted eosinophil activity against FITC-linked fibrinogen substrates.

21 capsulated fluorescent-bovine serum albumin (FITC-BSA) inside the gel.

22 isothiocyanate-labeled bovine serum albumin (FITC-BSA).

23 ed by analyzing 100 nm liposomes and albumin-FITC conjugate.

24 less than 6 min, about 10 min before albumin-FITC.

25 llophycocyanin (APC)-conjugated PDGFR-alpha, FITC-conjugated Sca-1, phycoerythrin (PE)-conjugated CD4

26 An FITC-labeled analogue of this polyamide can be detected

27 ing SYTO, DAPI dilactate, Hoechst 33342, and FITC dyes upon the pheochromocytoma PC-12 cells and RAW

28 xed, incubated with anti-biotin antibody and FITC-labeled goat anti-mouse antibody, and examined unde

29 fluorescent molecules, sulforhodamine-B and FITC-insulin in vitro, and absorption enhancement of sal

30 Apoptotic cell death was evaluated, and FITC conjugated bovine serum albumin across monolayer hR

31 calization of MitoTracker Red at 2 hours and FITC -p b-sCD44 was 17.4% (P < 0.001) and for FITC b-sCD

32 the ratio of bound and free Cy5-insulin and FITC-glucagon in the presence of their respective antibo

33 There was minimal penetration of NaF and FITC-D into the mid-vitreous in the in vivo experiments.

34 C insulin-stimulated Akt phosphorylation and FITC-insulin uptake that was partially reversed by SNP i

35 trans-endothelial electrical resistance and FITC-dextran permeability assays.

36 sepithelial electrical resistance (TEER) and FITC-Dextran permeability were evaluated to assess membr

37 sepithelial electrical resistance (TER)) and FITC-dextran (FD4) permeability over 14 days.

38 via hemolysis, cell viability, and AnnexinV-FITC/PI staining assays.

39 ranulation was assessed in vitro by AnnexinV-FITC/7-AAD staining and by measuring GM-CSF-induced medi

40 Anti-FITC-CAR-T cell activation and proliferation was strictl

41 ing using Fab fragments of anti-Dig and anti-FITC conjugated to peroxidase or alkaline phosphatase, r

42 pressing cancer cells and a "universal" anti-FITC-directed CAR-T cell.

43 Next, the four peptides were synthesized as FITC-labelled soluble peptides to study their direct upt

44 the cytoplasmic headpiece, thereby assigning FITC-SERCA as a nucleotide-free enzyme.

45 MMP-2 inhibitor, reduced pericyte-associated FITC-gelatin fluorescence and plasma leakage.

46 ength excitation, FITC/BSA-stabilized AuNCs (FITC/BSA-AuNCs) emitted fluorescence at 525 and 670nm, w

47 ein isothiocyanate (FITC)-labeled avidin (Av-FITC) as the template.

48 "on-the-fly" extraction and isolation of Av-FITC from raw serum and saliva samples along with real-t

49 s superior to that of commercially available FITC-antibody probe.

50 mulatory function of skin-derived Ag-bearing FITC(+)CD11c(+) dendritic cells in draining lymph nodes

51 4 +/- 2 A decrease in the proximity between FITC sites within the N-domain and a 9 +/- 3 A increase

52 Both FITC-TrapG and NIR-TrapG specifically imaged subcutaneou

53 In vitro binding of both FITC-TNYL-RAW and (64)Cu-DOTA-TNYL-RAW to cancer cells w

54 In vitro, both FITC-TNYL-RAW and (64)Cu-DOTA-TNYL-RAW were selectively

55 ng from free FITC from that of protein-bound FITC.

56 rticles, (AuNP@Cit/Cytc-FITC or AuNP@Cit/BSA-FITC), low limits of detection for Cyt c (LOD = 370 pM)

57 Using E2-BSA-FITC (fluorescein isothiocyanate) macromolecular complex

58 All E2-BSA-FITC binding neurons expressed L-type calcium channels.

59 s, revealed rapid Ca(2+) responses in E2-BSA-FITC binding neurons within minutes that culminated in a

60 nal markers labeled subpopulations of E2-BSA-FITC binding neurons.

61 ane of soma and neuronal processes in E2-BSA-FITC binding neurons.

62 agonist, DPN, partially competed for E2-BSA-FITC binding.

63 The same neurons in which E2-BSA-FITC induced a [Ca(2+)]i rise also exhibited activated p

64 No membrane binding was observed with BSA-FITC.

65 Migration toward DLN was evaluated by FITC skin painting, transgenic GFP skin tissue grafting,

66 pases and caspase-3 were detected in situ by FITC-VAD-fmk staining and caspase-3 substrate, respectiv

67 ine (CBM2a-RRedX) and paracrystalline (CBM17-FITC) cellulose, were used to differentiate the supramol

68 Anti-IgG antibody conjugated FITC-doped silica nanoparticles (FITC@SiO(2)-NH(2)-anti-

69 Conversely, FITC-labeled blastema cells were restricted to distal CT

70 CAR-T cells (specific for the corresponding FITC or PNE) to Her2-expressing tumor cells, and afford

71 of multi-shell nanoparticles, (AuNP@Cit/Cytc-FITC or AuNP@Cit/BSA-FITC), low limits of detection for

72 e contact sensitizer dibutyl phthalate (DBP)-FITC.

73 Both Nb and DBP-FITC induced extensive transcriptional changes that invo

74 tified no shared pathways between Nb and DBP-FITC, but revealed a type-I IFN (IFN-I) signature unique

75 the induction of Th2 immune responses by DBP-FITC.

76 In DBP-FITC-treated mice, TN DC upregulated expression of CD86

77 In contrast, the response to DBP-FITC was not affected by IFN-I receptor blockade, a find

78 ne (NAC) reduced ROS formation and decreased FITC-dextran leakage in Hcy treated HRECs.

79 ealed that CyLiPns could effectively deliver FITC-siRNA up to 360mum skin depth.

80 rum levels of lipopolysaccharide and dextran-FITC in mice with CDI that were exposed to PPI.

81 rum levels of lipopolysaccharide and dextran-FITC were measured to reflect the barrier permeability o

82 0-kDa dextran-Texas red, and 500-kDa dextran-FITC.

83 4 hours after AC injection of 40-kDa dextran-FITC.

84 model) using a newly developed 3-dimensional FITC-Imaris technique.

85 -induced change in FITC fluorescence enabled FITC/BSA-AuNCs to detect an ammonia product-related enzy

86 orescence quenching of AuNCs by H2O2 enabled FITC/BSA-AuNCs to ratiometrically detect the H2O2 produc

87 g protein completely eliminated SNP-enhanced FITC-insulin uptake.

88 Under single wavelength excitation, FITC/BSA-stabilized AuNCs (FITC/BSA-AuNCs) emitted fluor

89 arized 488 nm laser pulsed at 137 Hz excited FITC-glucagon.

90 aracellular permeability and size exclusion, FITC-labeled dextran ranging in size from 10 to 70 kDa w

91 ells for PEG-like molecules (CH3-PEG5K-FITC (FITC = fluorescein isothiocyanate) and eight-arm PEG20K-

92 , showed a 92% removal of unconjugated FITC (FITC clearance: 92%, RSD: 3%), while 79% of the HSA/FITC

93 o compete for TTR-binding with a fluorescent FITC-T4 probe.

94 A green emitting fluorophore, FITC (fluorescein isothiocyanate), whose luminescence is

95 tly dependent on the presence of both folate-FITC and FR-positive cells and was dose titratable with

96 ing the specificity of redirection by folate-FITC.

97 low folate-FITC uptake, areas of high folate-FITC uptake within human atherosclerotic plaques had an

98 Hot spots showed significantly higher folate-FITC uptake than cold spots (P < 0.001).

99 ugated to fluorescein isothiocyanate (folate-FITC) can redirect and regulate FITC-specific CAR-T cell

100 Compared with areas with low folate-FITC uptake, areas of high folate-FITC uptake within hum

101 ed to determine the exact location of folate-FITC uptake.

102 n from 20 patients and incubated with folate-FITC for 30 min.

103 ve cells and was dose titratable with folate-FITC switch.

104 sion was increased by approximately 70-fold (FITC-lectin binding), tumor vascular permeability was en

105 production, and serum IgE levels, following FITC sensitization and challenge.

106 itic cells in draining lymph nodes following FITC sensitization.

107 f injured explants were 6%, 40%, and 32% for FITC, TRITC, and TAMRA, respectively, compared to uninju

108 ITC -p b-sCD44 was 17.4% (P < 0.001) and for FITC b-sCD44 was 11.7% (P < 0.001) compared with b-album

109 rface adsorption of solute was strongest for FITC and weakest for TAMRA; no solutes negatively affect

110 Although we found FITC-labeled LPS in DLN within minutes of injection, dra

111 lution of fluorescence originating from free FITC from that of protein-bound FITC.

112 lymers were successfully immunoisolated from FITC-mouse antibody and pro-inflammatory cytokines.

113 orescein and "eat-me" phagocytic signals (Gd-FITC-LiLa) a) demonstrates high relaxivity that improves

114 The AuNP-GSH-FITC fluorescent probe was firstly developed and used fo

115 Using the AuNP-GSH-FITC probe, a droplet-based microfluidic fluorescent sen

116 athione-fluorescein isothiocyanate (AuNP-GSH-FITC) probe coupled with on-line droplet-based microflui

117 ntact hypersensitivity induced by the hapten FITC in combination with the sensitizing agent dibutyl p

118 o afford F-UiO NMOFs with exceptionally high FITC loadings, efficient fluorescence, and excellent rat

119 Conserved functionality of the HSA/FITC complex after EME was proven by a binding affinity

120 earance: 92%, RSD: 3%), while 79% of the HSA/FITC complex remained in the sample (protein retention:

121 (TRITC), fluorescein isothiocyanate isomer I(FITC) and DNA molecules, forming neutral LDH-nanosheet c

122 The pH-induced change in FITC fluorescence enabled FITC/BSA-AuNCs to detect an am

123 d to a loss of EBF with TPN (60% increase in FITC-dextran permeability, 40% decline in transepithelia

124 The ~ 20% inhibition in FITC-T4 binding observed for the mixtures reflecting med

125 concanamycin A-sensitive proton transport in FITC-loaded lysosomes.

126 Increased FITC-dextran leakage was observed from pre-existing vess

127 tight junction protein expression, increased FITC dextran leakage, decreased transcellular electrical

128 yers, 3h OGD and 24h reoxygenation increased FITC-dextran leakage, indicating disruption of intercell

129 y after photobleaching (MP-FRAP) of injected FITC-BSA, a 32.6% decrease in lymph speed was observed i

130 r erythrocyte flow and reduction of injected FITC-inulin were developed, each validated using the nep

131 l permeability, as revealed by intratracheal FITC-dextran tracking, serum Club Cell protein 16 measur

132 rhodamine-lactam and fluorescein isocyanate (FITC) leads to efficient metabolic incorporation of FITC

133 Green-emitting fluorescein-5-isothiocyanate (FITC) was conjugated to the amino groups of bovine serum

134 of unconjugated fluorescein isothiocyanate (FITC) after fluorescent labeling of human serum albumin

135 reaction between fluorescein isothiocyanate (FITC) and a model protein illustrates the utility of dir

136 conjugated with fluorescein isothiocyanate (FITC) and DOTA.

137 was tagged with fluorescein isothiocyanate (FITC) and made into nanoparticles (135 +/- 3 nm diameter

138 he high affinity fluorescein isothiocyanate (FITC) containing peptide, FITC-NH-(CH2)4-CO-pY-Q-G-L-S-a

139 t-treatment with Fluorescein Isothiocyanate (FITC) labeled 8-OHdG antibody.

140 imaging a 20 muM fluorescein isothiocyanate (FITC) labelling solution on mammalian tissue.

141 bes labeled with fluorescein isothiocyanate (FITC) or digoxigenin (Dig), followed by dual enzymatic l

142 inhibit anti-CR3-fluorescein isothiocyanate (FITC) staining of human neutrophils and anti-Dectin-1-FI

143 Fluorescein isothiocyanate (FITC) was conjugated to a mouse monoclonal antibody, Fc1

144 Fluorescein isothiocyanate (FITC) was covalently conjugated to a UiO NMOF to afford

145 ely labeled with fluorescein isothiocyanate (FITC), a probe that specifically reacts with Lys-515 in

146 ed fluorophores (fluorescein isothiocyanate (FITC), tetramethylrhodamine isothiocyanate (TRITC), and

147 contrast agent, fluorescein isothiocyanate (FITC), we aimed to explore the potential role of FR-beta

148 of Man-SNPs with fluorescein isothiocyanate (FITC)-concanavalin A (Con A) was determined using a fluo

149 permeability to fluorescein isothiocyanate (FITC)-conjugated dextran, and (ii) AJC structure using i

150 Specially, fluorescein isothiocyanate (FITC)-conjugated lectin from Lens culinaris (lentil) (FI

151 y the passage of fluorescein isothiocyanate (FITC)-dextran through endothelial monolayers.

152 demonstrated by fluorescein isothiocyanate (FITC)-dextran translocation to the circulation.

153 travenously with fluorescein isothiocyanate (FITC)-dextran.

154 se-2/9 activity, fluorescein isothiocyanate (FITC)-gelatin.

155 e, and increased fluorescein isothiocyanate (FITC)-inulin diffusion across the polarized cell monolay

156 microengines and fluorescein isothiocyanate (FITC)-labeled avidin (Av-FITC) as the template.

157 Fluorescein isothiocyanate (FITC)-labeled control siRNA delivered intranasally was f

158 The flux of fluorescein isothiocyanate (FITC)-labeled dextran across monolayers or the mouse epi

159 labeled insulin, fluorescein isothiocyanate (FITC)-labeled IAPP, anti-insulin, and anti-IAPP antibodi

160 ed, EC uptake of fluorescein isothiocyanate (FITC)-labeled insulin.

161 is, diffusion of fluorescein isothiocyanate (FITC)-labeled markers, and immunostaining for tight junc

162 A fluorescein isothiocyanate (FITC)-labeled peptide derived from the ATR cofactor, ATR

163 oefficients D of fluorescein isothiocyanate (FITC)-pepsin were measured in rennet gels across a range

164 incubation with fluorescein isothiocyanate (FITC)-tagged anti-human IgG.

165 s a quencher for fluorescein isothiocyanate (FITC).

166 ith pH-sensitive fluorescein isothiocyanate (FITC).

167 derivatised with fluorescein isothiocyanate (FITC).

168 ange [containing fluorescein isothiocyanate (FITC)], by utilizing a difluoromethylphenol-glucuronide

169 (2) = 0.964) and fluorescein isothiocyanate (FITC, R(2) = 0.973).

170 AHENTA with fluorescein-5-yl isothiocyanate (FITC) gave fluorescent probes that bound at nanomolar co

171 s (e.g., -COCH3, fluorescein isothiocyanate; FITC).

172 and model protein Fluorescein isothiocynate (FITC) Bovine Serum Albumin (BSA) conjugate incorporated

173 rgeting sequence peptide (F-PTS1, acetyl-C{K(FITC)}GGAKL) for investigating pH regulation of glycosom

174 70-kD FITC-dextran added apically to Myo5b KO intestinal expla

175 a intravital microscopic analysis of 150 kDa FITC-dextran-perfused blood vessels within discrete woun

176 sm to determine the binding of ConA to 4 kDa FITC-dextran by measuring the change in the rotational c

177 of this ligand, the ranges of ConA and 4 kDa FITC-dextran concentrations capable of being explored we

178 NaF and 40-kDa FITC-D reached higher peak concentrations and were clear

179 mL sodium fluorescein (NaF), 25 mg/mL 40-kDa FITC-D, or 25 mg/mL 70-kDa FITC-D, with (n = 9) or witho

180 Average 40- and 70-kDa FITC-D concentrations in the retina/choroid peaked at 54

181 on, and 48 and 72 hours after 40- and 70-kDa FITC-D injections, respectively.

182 , 25 mg/mL 40-kDa FITC-D, or 25 mg/mL 70-kDa FITC-D, with (n = 9) or without (n = 9) immediate euthan

183 ed from the eye more rapidly than was 70-kDa FITC-D.

184 rly demonstrated using green and red labels (FITC, DyLight 488, Alexa 568, and Alexa 596).

185 jugated lectin from Lens culinaris (lentil) (FITC-lectin) was tested on the different buffer conditio

186 paracellular permeability to macromolecular FITC-dextran.

187 SA was fluorescently labeled with 0.01 mg/mL FITC in a molar ratio of 10:1 in an Eppendorf tube for 3

188 conjugated FITC-doped silica nanoparticles (FITC@SiO(2)-NH(2)-anti-IgGNPs) used as the sensing nanob

189 structure, 20 nm fluorescent nanoparticles, FITC-BSA, and Alexa Fluor(R) 488 conjugated siRNA were e

190 .4-, and 2.9-fold greater for nanoparticles, FITC-BSA, and Alexa-siRNA, respectively, when compared t

191 permeability, assayed by the accumulation of FITC-dextran in plasma.

192 ulate the solvent-accessible surface area of FITC and FMP bound to SERCA crystal structures, revealin

193 alitatively related to diffusion behavior of FITC-pepsin in these dairy gels.

194 Binding of FITC-TNYL-RAW and (64)Cu-DOTA-TNYL-RAW to CT26 and PC-3M

195 Examination of DC capture of FITC from painted skin, DC isolation from skin explant c

196 usion, micropuncture, and renal clearance of FITC-inulin to examine the effects of tubular glucose on

197 e experimental results for the collection of FITC-labeled bovine serum albumin (BSA, 0.033nM) were as

198 in KO mice indicated more the development of FITC sensitization than an irritative reaction.

199 sity of the ML and PCL from the diffusion of FITC-dextran dissolved in the ASL of unperturbed, well-d

200 eads to efficient metabolic incorporation of FITC and rhodamine-lactam into bacterial peptidoglycan.

201 cules through site-specific incorporation of FITC or grafting of a peptide neo-epitope (PNE) into the

202 LB/c mice received subcutaneous injection of FITC-conjugated dextran (DX) probes into the ear skin an

203 ements confirmed the specific interaction of FITC-tagged TMPMs with their respective TMH.

204 ay to monitor binding and internalization of FITC labeled POS by ARPE-19, human fetal RPE (hfRPE), an

205 by measuring apical-basolateral movements of FITC-dextran, respectively.

206 Large numbers of FITC(+) epidermal cells became detectable 12-24 hours af

207 F-actin staining with phalloidin, passage of FITC-conjugated dextran through a monolayer of lung epit

208 as assessed after 14 days after perfusion of FITC-dextran.

209 Transcardial perfusion of FITC-labeled albumin suggested that local ischemia was a

210 tic rats exhibited increased permeability of FITC-albumin, and a single norrin injection restored BRB

211 , cocaine treatment enhanced permeability of FITC-dextran suggesting a breach in the barrier.

212 t by confirming dose-dependent permeation of FITC-insulin and sulforhodamine-B.

213 rular filtration, as assessed by the rate of FITC-inulin clearance from the blood, which, in turn, wa

214 The recognition of FITC-APBA to sialylated TRITC-AF leads to the FRET signa

215 these models, as shown by the reductions of FITC-dextran gut translocation, serum interleukin-6 (IL-

216 increased uptake and decreased secretion of FITC-labeled Albumin.

217 ionally, a concentration-dependent uptake of FITC labeled Bla g 2 by fibrocytes was observed, but was

218 trate macropinocytosis through the uptake of FITC-dextran and amiloride inhibition of Francisella LVS

219 antibody Erbitux enabled selective uptake of FITC-labeled Ki-67 antibody TuBB-9 in EGFR-positive cell

220 myocyte diameter and length were measured on FITC-wheat germ agglutinin-stained sections.

221 extramers and with PE-, allophycocyanin-, or FITC-based reagents.

222 igned to contain a donor/acceptor FRET pair (FITC and DABCYL).

223 droplets containing size-selected particles, FITC-albumin, or Lsr-F were recovered, re-electrosprayed

224 rescein isothiocyanate) and eight-arm PEG20K-FITC) was at least 10-80-fold greater than that of 293T

225 type cells for PEG-like molecules (CH3-PEG5K-FITC (FITC = fluorescein isothiocyanate) and eight-arm P

226 -PEG5K-NH2) and PEG-like molecule (CH3-PEG5K-FITC, CH3-PEG5K-SHPP, and CH3-PEG5K-NIR797) was14-137 ng

227 in isothiocyanate (FITC) containing peptide, FITC-NH-(CH2)4-CO-pY-Q-G-L-S-amide (8; Kd = 0.35 microM)

228 phosphatidylserine and binds prothrombinase (FITC Xa.factor Va).

229 Punctate FITC signal was observed on plasma membrane of soma and

230 nate (folate-FITC) can redirect and regulate FITC-specific CAR-T cell activity toward folate receptor

231 s of the FITC@SiO(2)-NH(2)-anti-IgG released FITC molecules, leading to an amplified fluorescence det

232 s, but only when pretargeted with a relevant FITC-labelled antitumour antibody.

233 Several FITC-tagged TMPMs specifically bound to Cdr1p and blocke

234 rin(+) epidermal cells exhibited significant FITC signals.

235 tic and fluorescent core/shell of Fe3O4@SiO2(FITC) was tested for their ability to deliver Notch-1 sh

236 as Notch-1 shRNA in this report, Fe3O4@SiO2(FITC)/PEI-FA can be exploited as a novel, non-viral, and

237 agnetic targeting capabilities of Fe3O4@SiO2(FITC)/PEI-FA, our results show that by complexing with a

238 ignificant preferential uptake of Fe3O4@SiO2(FITC)/PEI-FA/Notch-1 shRNA nanocomplex by MDA-MB-231 cel

239 Our results showed that Fe3O4@SiO2(FITC)/PEI-FA/Notch-1 shRNA nanoparticles are 64 nm in di

240 unoreaction was achieved via the Fc-specific FITC@SiO(2)-NH(2)-anti-IgG binding to the captured anti-

241 udies, and the nuclear localization of ssDNA-FITC suggest that nano-LDHs have potential application a

242 ive AuNCs were used as an internal standard, FITC/BSA-AuNCs offered a sensitive and reversible ratiom

243 In fate-mapping studies, FITC-labeled vertebra periosteal cells were detected in

244 We used enzyme reverse mode to synthesize FITC monophosphate (FMP) on SERCA, producing a phosphory

245 and glycolic acid residue and an N-terminal FITC fluorophore appended via a thiourea linkage.

246 jugate showed capture efficiency better than FITC-G6-COOH-5aSlex conjugate.

247 ation-specific proteolysis demonstrated that FITC labeling does not induce closure of the cytoplasmic

248 The FITC-dextrans (4 and 20 kDa) were able to migrate in the

249 e second irradiation at 490 nm activated the FITC-labeled TuBB-9, which caused inactivation of the Ki

250 with a static adhesion assay ex vivo and the FITC-lectin perfusion method in vivo.

251 At a higher dose (120 nmol/kg), the FITC-sODN-mmp9 probe revealed significant knockdown of M

252 ross-links and instantaneously liberates the FITC-BSA under 2 cm thick tissue.

253 t photomultiplier tubes for detection of the FITC and Cy5 signal.

254 that internalized POS, the brightness of the FITC signal from the cells, and the surface density of t

255 Most (>90%) of the FITC(+) epidermal cells expressed Langerin, and >95% of

256 The alkali hydrolysis of the FITC@SiO(2)-NH(2)-anti-IgG released FITC molecules, lead

257 e analytical performance evaluated using the FITC@SiO(2)-NH(2)-anti-IgGNPs as sensing nanobioprobe, M

258 This FITC is conjugated in end-terminal of activatable fluoro

259 This FITC-conjugated BSA acted as a template for the synthesi

260 is study when purified aggrecan was added to FITC-conjugated hyaluronan, no internalization of hyalur

261 The purified TAT-SOD was conjugated to FITC-MSN forming FMSN-TAT-SOD.

262 % for injured and sliced explants exposed to FITC).

263 he draining lymph node following exposure to FITC and in reduced expression of CCR7 and MMP-9 in sple

264 NO production, and elevating permeability to FITC-dextran 70 in monolayers of cells expressing wild-t

265 PAF failed to increase permeability to FITC-dextran 70 in monolayers of cells transfected with

266 ) and decreased paracellular permeability to FITC-Dextran, and this effect was abolished by treatment

267 ased paracellular intestinal permeability to FITC-dextran.

268 ined via functional assay of permeability to FITC-dextran.

269 ier in vivo by percutaneous sensitization to FITC in TGM3/KO (n=64) and C57BL/6 wild-type (WT) mice (

270 arrier function and higher susceptibility to FITC sensitization indicating that TGM3 has a significan

271 As in vivo tracer, FITC penetration from skin surface followed by two-photo

272 Negatively charged and unconjugated FITC was extracted electrokinetically into the SLM and t

273 (TDA), showed a 92% removal of unconjugated FITC (FITC clearance: 92%, RSD: 3%), while 79% of the HS

274 Using FITC dextran conjugates, we demonstrate that sea urchin

275 ne exclusively expressing Nox1 (HT-29) using FITC-labeled NoxA1ds.

276 Leukostasis was assessed using FITC-conjugated ConA to label leukocytes.

277 s were measured on choroidal flatmount using FITC-dextran.

278 luorescence polarization assay that utilized FITC-labeled peptide ligands.

279 r cell line, as evidenced from the annexin V-FITC/PI assay.

280 Flow cytometry based-Annexin V-FITC/PI double-staining was used to further quantify cel

281 Annexin V-FITC/PI staining assays confirm that the cell death indu

282 ed by WST-1 cytotoxicity assay and annexin V-FITC/propidium iodide (PI) staining as apoptosis-necrosi

283 for PET imaging, and a fluorescent version, FITC-PEG4-cRGD2, for in vitro work).

284 characterize FMP-SERCA (ATP.E2 state) versus FITC-SERCA in Ca(2+)-free, Ca(2+)-bound, and actively cy

285 e, beginning 1 hour after injection, whereas FITC-D-injected eyes did not show elevated retina/choroi

286 With FITC as the reference signal, the mono- and dual-color e

287 Further quantitative analysis with FITC-Imaris technique showed a significant reduction in

288 ional animals, perfluorocarbon combined with FITC (fluorescein isothiocyanate) was administered for p

289 decreased probe accessibility compared with FITC-SERCA, indicating that ATP exhibits enhanced dynami

290 The assay involves derivatization with FITC followed by CE-LIF using 0.5 mM hydroxyl propyl-bet

291 Mice were anaesthetized, gavaged with FITC-dextran for measures of gastrointestinal permeabili

292 mary detection reagents were identified with FITC-labeled probes and analyzed by fluorescence microsc

293 ragments are site-specifically modified with FITC using genetically encoded noncanonical amino acids.

294 as Fu(live), the animals were perfused with FITC-dextran and Fu determined.

295 is in mice was assessed after perfusion with FITC-conjugated concanavalin A.

296 ent, corneas were collected and stained with FITC-conjugated CD31 and LYVE-1 followed by Cy3-conjugat

297 P-biotin conjugate followed by staining with FITC-avidin.

298 n neuroblastoma (SK-N-SH) cells treated with FITC conjugated Abeta1-40 localized Abeta to the nucleus

299 microvascular networks were visualized with FITC conjugated BSI-lectin labeling and arteriole diamet

300 proteolysis, measured by gelatin zymography, FITC-gelatin conversion, and DQ-gelatin degradation assa